Estimated antimicrobial susceptibility of oral beta-lactam antibiotics and their suitability for empirical treatment of uncomplicated urinary tract infections in Slovenia

  • Kristina Nadrah Department of Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia
  • Iztok Štrumbelj Oddelek za medicinsko mikrobiologijo Murska Sobota, Nacionalni laboratorij za zdravje, okolje in hrano
  • Bojana Beović Klinika za infekcijske bolezni in vročinska stanja, Univerzitetni klinični center Ljubljana, SlovenijaMedicinska Fakulteta, Univerza v Ljubljani

Abstract

Background: Uncomplicated urinary tract infections are among the most common infections in young healthy women. When treating such infections we use narrow-spectrum antibiotics with activity against the most common pathogens. The treatment of such infections is usually empirical, therefore in our study we estimated the susceptibility of the most common isolates to oral betalactam antibiotics to determine whether they are an acceptable alternative in case of contraindications to first-line agents.
Methods: We used a theoretical distribution of the frequency of urinary tract pathogens and antimicrobial susceptibilities from clinical urinary cultures in women to calculate an estimate of overall susceptibility of the pathogens using a mathematical model.
Results: The estimated susceptibility to ampicillin was low (50 %), but much higher for cephalosporins of 1st to 3rd generation (88 % – 90 %).
Conclusion: The mathematical model for susceptibility estimation represents an interesting tool for predicting clinical efficacy of antibiotics, based on local antibiotic susceptibility and frequency of pathogens. Our results show that among betalactam antibiotics, 1st generation cephalosporins are suitable for the treatment of uncomplicated cystitis.

Downloads

Download data is not yet available.

References

Bonkat GC, Pickard RC, Bartoletti R, Bruyère F, Geerlings S, Wagenlehner F, et al. Guidelines on Urological Infections 2017 [Internet]. European Association of Urology; 2017 [cited 2017 Sep 7]. Available from: http://uroweb.org/guideline/urological-infections/

Hooton TM. Acute Complicated cystitis and pyelonephritis. [Internet]. 08/17. Available from: https://www.uptodate.com/contents/acute-complicated-cystitis-and pyelonephritis?source=search_result&search=acute+complicated+pyelonephritis&selectedTitle=1%7E4

Hooton TM. Uncomplicated Urinary Tract Infection. N. Engl. J. Med. 2012;366(11):1028–37.

Tandogdu Z, Wagenlehner FME. Global epidemiology of urinary tract infections. Curr. Opin. Infect. Dis. 2016;29(1):73–9.

Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 2011;52(5):e103–20.

Štrumbelj I, Pirš M, Berce I, Fišer J, Golle A, Harlander T, et al. Občutljivost pogostih bakterij za antbiotike v Sloveniji po podatkih SKIJOP, 2017-2016. In: Beović B, Lejko Zupanc T, Tomažič J, editors. Stopenjska Diagn. Zdr. Pogostih Okužb. Ljubljana: Sekcija za protimikrobno zdravljenje SZD; 2017. p. 43–52.

Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women. Clin. Infect. Dis. 1999;29(4):745–58.

The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0, 2018. [Internet]. EUCAST; [cited 2018 Mar 11]. Available from: http://www.eucast.org/clinical_breakpoints/

Paterson DL. “Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy. Clin. Infect. Dis. 2004;38(Supplement_4):S341–5.

The European Committee on Antimicrobial Susceptibility Testing. EUCAST breakpoints for oral cephalosporins. Guidance Document. [Internet]. EUCAST; 2012 [cited 2018 Mar 11]. Available from: http://www.eucast.org/guidance_documents/

Vahlensieck W, Perepanova T, Bjerklund Johansen TE, Tenke P, Naber KG, Wagenlehner FME. Management of Uncomplicated Recurrent Urinary Tract Infections. Eur. Urol. Suppl. 2016;15(4):95–101.

Jorgensen S, Zurayk M, Yeung S, Terry J, Dunn M, Nieberg P, et al. Risk factors for early return visits to the emergency department in patients with urinary tract infection. Am. J. Emerg. Med. 2018;36(1):12–7.

Published
2019-10-28
How to Cite
1.
Nadrah K, Štrumbelj I, Beović B. Estimated antimicrobial susceptibility of oral beta-lactam antibiotics and their suitability for empirical treatment of uncomplicated urinary tract infections in Slovenia. TEST ZdravVestn [Internet]. 28Oct.2019 [cited 9Apr.2020];88(9-10):458-3. Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2855
Section
Case report, short scientific article